Founder | J. Craig Venter |
---|---|
Type | Private company |
Location | |
Area served
|
Worldwide |
Products |
Instruments Reagents Bioinformatics Tools (Full list of products) |
Services | (Full list of services) |
|
|
Key people
|
|
Subsidiaries |
|
Website | SyntheticGenomics |
Synthetic Genomics Inc. (SGI), is a private company located in La Jolla, California that is focused on the field of synthetic biology. SGI designs and builds biological systems to address global sustainability problems.
Synthetic biology is an interdisciplinary branch of biology and engineering, combining fields such as biotechnology, evolutionary biology, molecular biology, systems biology, biophysics, computer engineering, and genetic engineering. Synthetic Genomics uses techniques such as software engineering, bioprocessing, bioinformatics, biodiscovery, analytical chemistry, fermentation, cell optimization, and DNA synthesis to design and build biological systems. The company produces or performs research in the fields of sustainable bio-fuels, insect resistant crops, transplantable organs, targeted medicines, DNA synthesis instruments as well as a number of biological reagents.
SGI mainly operates in three end markets: research, bioproduction and applied products. The research segment focuses on genomics solutions for academic and commercial research organizations. The commercial products and services include instrumentation, reagents, DNA synthesis services, and bioinformatics services and software. In 2015, the company launched the BioXP 3200 system, a fully automated benchtop instrument that produces DNA fragments from many different sources for genomic data.